| Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) (NCT00493129) | M.D. Anderson Cancer Center | 2004-07-01 |
| A Phase II Study of CC-5013 in Myelofibrosis (NCT00087672) | M.D. Anderson Cancer Center | 2004-07-01 |
| Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma (NCT00290511) | M.D. Anderson Cancer Center | 2004-06-29 |
| Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia (NCT00412594) | M.D. Anderson Cancer Center | 2004-06-10 |
| Locus of Control and Spirituality in Palliative Care Patients (NCT00477243) | M.D. Anderson Cancer Center | 2004-06-03 |
| Prevalence of Endometrial Abnormalities In Obese Women (NCT00500591) | M.D. Anderson Cancer Center | 2004-06-01 |
| Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions (NCT00527891) | M.D. Anderson Cancer Center | 2004-06-01 |
| RAD001 in Recurrent Endometrial Cancer Patients (NCT00087685) | M.D. Anderson Cancer Center | 2004-06-01 |
| Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS (NCT00520468) | M.D. Anderson Cancer Center | 2004-06-01 |
| Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors (NCT00086762) | M.D. Anderson Cancer Center | 2004-06-01 |
| Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients (NCT00323557) | M.D. Anderson Cancer Center | 2004-06-01 |
| Genetic Susceptibility in Migrant Farmworker Children (NCT00501280) | M.D. Anderson Cancer Center | 2004-06-01 |
| Epidemiology Controls Using Healthy Participants (NCT00476632) | M.D. Anderson Cancer Center | 2004-06-01 |
| Use of Nesiritide in the Management of Acute Diastolic Heart Failure (NCT00083772) | M.D. Anderson Cancer Center | 2004-05-17 |
| Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients (NCT00504920) | M.D. Anderson Cancer Center | 2004-05-01 |
| Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors (NCT00078845) | M.D. Anderson Cancer Center | 2004-05-01 |
| Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (NCT00081887) | M.D. Anderson Cancer Center | 2004-05-01 |
| ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin (NCT00054691) | M.D. Anderson Cancer Center | 2004-05-01 |
| Iressa Study in Patients With Salivary Gland Cancer (NCT00509002) | M.D. Anderson Cancer Center | 2004-05-01 |
| Contemporary Characteristics of Penile Cancer (NCT04996849) | M.D. Anderson Cancer Center | 2004-04-22 |
| Chemoradiation-Induced Nausea and Emesis: Quality of Life (NCT00394602) | M.D. Anderson Cancer Center | 2004-04-07 |
| Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A (NCT00221039) | M.D. Anderson Cancer Center | 2004-04-02 |
| Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer (NCT00093379) | M.D. Anderson Cancer Center | 2004-04-01 |
| RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma (NCT00081874) | M.D. Anderson Cancer Center | 2004-04-01 |
| Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) (NCT00459524) | M.D. Anderson Cancer Center | 2004-04-01 |
| Cognitive Training in Attenuating Attention Deficits/Child Treatment for Cancer (NCT00498719) | M.D. Anderson Cancer Center | 2004-04-01 |
| Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL) (NCT00500240) | M.D. Anderson Cancer Center | 2004-04-01 |
| Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials (NCT00500513) | M.D. Anderson Cancer Center | 2004-04-01 |
| Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes (NCT00451997) | M.D. Anderson Cancer Center | 2004-03-01 |
| Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients (NCT00661544) | M.D. Anderson Cancer Center | 2004-03-01 |
| Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma (NCT00081861) | M.D. Anderson Cancer Center | 2004-03-01 |
| Gliogene: Brain Tumor Linkage Study (NCT00418899) | M.D. Anderson Cancer Center | 2004-02-12 |
| PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery (NCT00276523) | M.D. Anderson Cancer Center | 2004-02-01 |
| Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning (NCT00418691) | M.D. Anderson Cancer Center | 2004-02-01 |
| A Study of Actonel for the Prevention of Bone Loss (NCT00452439) | M.D. Anderson Cancer Center | 2004-02-01 |
| Melatonin Postoperative Sleep Study in Breast Cancer Patients (NCT00506064) | M.D. Anderson Cancer Center | 2004-02-01 |
| Colon Cancer Screening in First-Degree Relatives of Hispanic Colorectal Cancer (CRC) Patients (NCT00838318) | M.D. Anderson Cancer Center | 2004-02-01 |
| Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer (NCT00479089) | M.D. Anderson Cancer Center | 2004-02-01 |
| Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma (NCT00387023) | M.D. Anderson Cancer Center | 2004-02-01 |
| Gemox as First and Second Line Therapy in Unknown Primary Cancer (NCT00353145) | M.D. Anderson Cancer Center | 2004-02-01 |
| OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer (NCT00076310) | M.D. Anderson Cancer Center | 2004-01-28 |
| Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes (NCT00075010) | M.D. Anderson Cancer Center | 2004-01-23 |
| Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma (NCT00504634) | M.D. Anderson Cancer Center | 2004-01-01 |
| G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients (NCT00499343) | M.D. Anderson Cancer Center | 2004-01-01 |
| Smoking Cessation for HIV/AIDS Patients (NCT00502827) | M.D. Anderson Cancer Center | 2004-01-01 |
| Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) (NCT00525785) | M.D. Anderson Cancer Center | 2004-01-01 |
| Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NCT00429026) | M.D. Anderson Cancer Center | 2004-01-01 |
| Natrecor in Pulmonary Hypertension (NCT00075179) | M.D. Anderson Cancer Center | 2003-12-31 |
| Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma (NCT00506779) | M.D. Anderson Cancer Center | 2003-12-29 |
| Fludarabine, Cyclophosphamide, and Rituximab - High Dose Frontline (NCT00794820) | M.D. Anderson Cancer Center | 2003-12-01 |
| Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer (NCT00068432) | M.D. Anderson Cancer Center | 2003-12-01 |
| Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma (NCT00067639) | M.D. Anderson Cancer Center | 2003-12-01 |
| Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium (NCT00082719) | M.D. Anderson Cancer Center | 2003-12-01 |
| Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML) (NCT00074750) | M.D. Anderson Cancer Center | 2003-12-01 |
| Pain Management Following TRAM Flap for Breast Reconstruction (NCT00500565) | M.D. Anderson Cancer Center | 2003-12-01 |
| Clofarabine Combinations in Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS) and Myeloid Blast Phase Chronic Myeloid Leukemia (CML) (NCT00067028) | M.D. Anderson Cancer Center | 2003-12-01 |
| Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support (NCT00506857) | M.D. Anderson Cancer Center | 2003-11-01 |
| Longitudinal Study of Multiple Symptoms in Advanced Lung Cancer (NCT00422500) | M.D. Anderson Cancer Center | 2003-11-01 |
| The Effect of Donepezil on Sedation and Other Symptoms (NCT00352664) | M.D. Anderson Cancer Center | 2003-11-01 |
| Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer (NCT00338728) | M.D. Anderson Cancer Center | 2003-10-03 |
| Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas (NCT00412542) | M.D. Anderson Cancer Center | 2003-10-01 |
| Extraperitoneal Lymph Node Dissection in Patients With Cervical Cancer (NCT00500435) | M.D. Anderson Cancer Center | 2003-10-01 |
| Busulfan and Fludarabine in Patients With AML and MDS (NCT00502905) | M.D. Anderson Cancer Center | 2003-10-01 |
| Study of Three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS) (NCT00067808) | M.D. Anderson Cancer Center | 2003-10-01 |
| Oral Valganciclovir Versus Valacyclovir (NCT00562770) | M.D. Anderson Cancer Center | 2003-09-01 |
| Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma (NCT00506129) | M.D. Anderson Cancer Center | 2003-09-01 |
| 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients (NCT00504660) | M.D. Anderson Cancer Center | 2003-09-01 |
| Letrozole in Patients With Ovarian Tumors (NCT00505661) | M.D. Anderson Cancer Center | 2003-09-01 |
| Genetic Study of Chronic Lymphocytic Leukemia Families (NCT00503256) | M.D. Anderson Cancer Center | 2003-09-01 |
| Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer (NCT00336791) | M.D. Anderson Cancer Center | 2003-09-01 |
| CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) (NCT00346801) | M.D. Anderson Cancer Center | 2003-09-01 |
| Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma (NCT01538472) | M.D. Anderson Cancer Center | 2003-09-01 |
| Elizabeth Registry for Low Grade Ovarian Cancer (NCT00345709) | M.D. Anderson Cancer Center | 2003-09-01 |
| Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma (NCT00290433) | M.D. Anderson Cancer Center | 2003-09-01 |
| Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers (NCT00503035) | M.D. Anderson Cancer Center | 2003-08-20 |
| Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients (NCT00386373) | M.D. Anderson Cancer Center | 2003-08-01 |
| Rituximab Maintenance After Autologous Transplantation (NCT01103388) | M.D. Anderson Cancer Center | 2003-08-01 |
| Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma (NCT00338988) | M.D. Anderson Cancer Center | 2003-08-01 |
| Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial (NCT05041946) | M.D. Anderson Cancer Center | 2003-07-16 |
| Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST (NCT00500188) | M.D. Anderson Cancer Center | 2003-07-01 |
| Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets (NCT00074763) | M.D. Anderson Cancer Center | 2003-07-01 |
| Molecular Epidemiology of Acute Myelogenous Leukemia (NCT00502983) | M.D. Anderson Cancer Center | 2003-06-23 |
| Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome (NCT00065143) | M.D. Anderson Cancer Center | 2003-06-23 |
| Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide (NCT00283621) | M.D. Anderson Cancer Center | 2003-06-02 |
| Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer (NCT00063258) | M.D. Anderson Cancer Center | 2003-06-01 |
| Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage (NCT00890656) | M.D. Anderson Cancer Center | 2003-06-01 |
| Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer (NCT00500110) | M.D. Anderson Cancer Center | 2003-06-01 |
| Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer (NCT00062023) | M.D. Anderson Cancer Center | 2003-06-01 |
| Wild Type p53 Adenovirus for Oral Premalignancies (NCT00410865) | M.D. Anderson Cancer Center | 2003-06-01 |
| Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy (NCT00052221) | M.D. Anderson Cancer Center | 2003-05-20 |
| Screening for Gynecologic Cancers in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Patients (NCT00508846) | M.D. Anderson Cancer Center | 2003-05-01 |
| Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata (NCT00063076) | M.D. Anderson Cancer Center | 2003-05-01 |
| Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008 (NCT00084825) | M.D. Anderson Cancer Center | 2003-05-01 |
| Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases (NCT00080678) | M.D. Anderson Cancer Center | 2003-05-01 |
| Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant (NCT00082706) | M.D. Anderson Cancer Center | 2003-04-23 |
| High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML) (NCT00050531) | M.D. Anderson Cancer Center | 2003-04-01 |
| Randomized Double Cord Blood Transplant Study (NCT00067002) | M.D. Anderson Cancer Center | 2003-04-01 |
| Measurement of Pain and Other Symptoms of Non-Small Cell Lung Cancer (NSCLC) Patients Following Thoracic Surgery (NCT00501319) | M.D. Anderson Cancer Center | 2003-04-01 |
| PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer (NCT00059618) | M.D. Anderson Cancer Center | 2003-04-01 |
| Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) Patients (NCT00423436) | M.D. Anderson Cancer Center | 2003-04-01 |